Common variants near the APOA5 gene are associated with modestly higher average triglyceride levels. They contribute a small shift, not a diagnosis, and very high triglycerides mainly matter because of pancreatitis risk.
Triglycerides are the main form in which the body stores extra energy from food. After a meal, the body packages unused fat and sugar into triglycerides and sends them through the bloodstream to fat tissue for storage. A fasting blood test measures how much of this fat is circulating in the blood at any given time, and persistently high levels are one of several factors that clinicians weigh when assessing cardiovascular risk and, at very high levels, the risk of a specific condition called pancreatitis.
Triglyceride levels are generally categorized as follows (measured in mg/dL after fasting):
Most of the cardiovascular-risk conversation around triglycerides concerns the "high" range and above, alongside other risk factors like LDL cholesterol, blood pressure, and diabetes. A separate concern kicks in at much higher levels: when triglycerides climb into the range of roughly 1,000 mg/dL or higher, the risk of acute pancreatitis — sudden, painful inflammation of the pancreas — rises substantially. This is why very high triglycerides are treated differently from moderately high ones; the concern shifts from long-term cardiovascular risk to a more immediate, though still relatively uncommon, medical emergency.
Triglyceride levels are shaped by a mix of diet, physical activity, alcohol use, body weight, certain medical conditions (like poorly controlled diabetes), some medications, and genetics. On the genetic side, one of the best-studied regions sits on chromosome 11, in and around a cluster of genes that includes APOA5. APOA5 is involved in regulating an enzyme that helps clear triglyceride-carrying particles from the blood.
Two common variants in this region are discussed here:
It's important to be realistic about what "associated with higher triglycerides" means here: each of these variants shifts average triglyceride levels by a modest amount across large groups of people. Carrying one, or even two, copies of the higher-triglyceride version of either variant is not a diagnosis of high triglycerides, does not predict pancreatitis on its own, and does not replace an actual blood test. Diet, weight, alcohol intake, and underlying conditions like diabetes typically have a much larger effect on an individual's triglyceride level than either of these variants does by itself.
Genes and variants:
Clinical thresholds: Fasting triglyceride categories in common clinical use: normal <150 mg/dL, borderline high 150–199 mg/dL, high 200–499 mg/dL, very high ≥500 mg/dL. The Endocrine Society's 2012 clinical practice guideline (Berglund et al., 2012, J Clin Endocrinol Metab; PMID 22962670) further subdivides severe hypertriglyceridemia into a "severe" category (1,000–1,999 mg/dL) and a "very severe" category (≥2,000 mg/dL), and identifies levels above approximately 1,000 mg/dL as the range in which pancreatitis risk becomes clinically significant, while noting the specific cutoff is not a sharp biological boundary.
Interpreting these variants: Common variants such as rs662799 and rs964184 are appropriately understood as contributing to the polygenic architecture of triglyceride levels — each has a small, population-level average effect and neither is diagnostic for an individual. They are distinct from rare, high-penetrance APOA5 loss-of-function variants or other monogenic causes of severe hypertriglyceridemia (e.g., familial chylomicronemia syndrome, which involves genes such as LPL, APOC2, APOA5, GPIHBP1, or LMF1 and produces much larger elevations). This entry concerns the common, population-level variants only, not rare monogenic disease.
No treatment or dietary recommendations are implied by carrying either variant; triglyceride management is guided by an individual's actual measured lipid panel, overall cardiovascular risk profile, and clinical evaluation, not by genotype at these loci.
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about High Triglycerides (APOA5-Associated) comes down to these specific, well-studied positions — not a diagnosis.
Triglycerides are the main form in which the body stores unused calories as fat, circulating in the blood between meals and after eating. Persistently high levels are one factor in cardiovascular risk assessment, and very high levels sharply raise the risk of acute pancreatitis.
No. These are common variants that shift average triglyceride levels by a modest amount across large populations. They are not a diagnosis, and only an actual fasting blood test can tell you your triglyceride level.
rs964184 has been linked to both traits in genetic studies, but the association most consistently and strongly replicated across large studies is with triglyceride levels; any HDL-cholesterol association reported is smaller and likely reflects the well-known inverse relationship between triglycerides and HDL cholesterol.
Clinical guidelines generally flag a substantially increased pancreatitis risk once triglycerides rise above approximately 1,000 mg/dL, a range classified as 'severe' hypertriglyceridemia, though risk is not confined to one sharp cutoff.
No. This entry does not make treatment or dietary recommendations. Management of triglyceride levels is based on an individual's actual lab results and overall health picture, established through evaluation by a clinician, not on genotype at these variants.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.